Webinars
Caris Webinar Archive
The Caris Life Sciences Educational Webinar Series provides informational and educational discussions covering a wide variety of topics, like molecular profiling education, clinical trials, artificial intelligence and machine learning in precision medicine and innovations affecting patient treatment.
Treat the Tumor, Not the False Positives: Correcting for Clonal Hematopoies in Liquid Biopsy
The Next Evolution of Blood-Based Profiling: Overcoming Liquid Biopsy Limitations
Molecular Insights to Improve Diagnostic Accuracy
Leveraging Molecular Testing to Adhere to Industry
Clinical Trial Spotlight: Phase 2 study of Repotrectinib in ROS1 Advanced NSCLC and NTRK Advanced Solid Tumors
Current Liquid Biopsy Limitations – Opportunities for Cancer Diagnostics Evolution
Clinical Trial Spotlight: Elevation Oncology – Detection and treatment of NRG1 fusions in solid tumors – Phase 2 CRESTONE study
Decoding Depth of Coverage (DNA) and Read Count (RNA) – What these mean and why they matter
Mirati Therapeutics Study 849-001 KRYSTAL – 1
Mirati Therapeutics Study KRYSTAL-1 Updated Data and Upcoming Studies
Clinical Trial Spotlight: IDEAYA Biosciences – PKC inhibitor darovasertib effectively targets GNAQ-11 mutations in cancer
2021 ASCO Oral Presentation Review: Immunotherapy Resistance in Leiomyosarcoma
Clinical Impact of Human Leukocyte Antigen(HLA) Genes in Cancer Immunotherapy
Guideline-Directed Profiling for Gynecological Malignancies
Molecular Artificial Intelligence – State of AI in Precision Medicine
Tumor Mutational Burden – Technological and Clinical Perspective
The Central Dogma of Molecular Biology – An Educational Primer for Precision Oncology
Precision Oncology for Breast and Lung Cancer – Key Findings _ Summary From 2020 ASCO and AACR
WES and LOH Testing – A Clinical Perspective
Micro-dissection and Limited Guideline-Directed-Profiling-for-Pancreatic-Cancer Testing
Micro-dissection and Limited Tissue Testing
Guideline-Directed Profiling for Breast and Head and Neck Cancers
RNA is the Superior Method of Gene Fusion Analysis with Dr. David Spetzler
Biomarker Guided Therapeutics in Colorectal Cancer with
AI-Driven Cancer Type Similarity Assessment for CUP Cases – MI GPSai™
Exploring Guideline-Directed Profiling by RNA Sequencing for NSCLC
NCCN Guidelines – Caris Value
PD-L1 Testing by Tumor Type – Testing with the Appropriate Technology and Clones
Biomarker-Guided Therapeutics in Cancer of Unknown Primary with David Arguello M.D., Manager-Biomarker, Drug Intelligence
All content is the property of Caris Life Sciences (Caris) and may not be utilized, reproduced or repurposed in any format without the express written consent of Caris. Much of the content contains or references trademarks, copyrights, patents, or other proprietary rights of Caris. The information and intellectual property included are the exclusive property of Caris. Removing or altering any copyright or other legal notice is expressly prohibited.